Filtered By:
Specialty: Cardiology
Drug: Insulin

This page shows you your search results in order of date. This is page number 13.

Order by Relevance | Date

Total 191 results found since Jan 2013.

Association of Sympathovagal Imbalance With Cardiovascular Risks in Young Prehypertensives
In conclusion, SVI in young prehypertensives is due to both increased sympathetic and decreased vagal tone. CV risks are linked to SVI and SVI predicts cardiac risk in prehypertensives.
Source: The American Journal of Cardiology - September 16, 2013 Category: Cardiology Authors: Gopal K. Pal, Chandrasekaran Adithan, Palghat H. Ananthanarayanan, Pravati Pal, Nivedita Nanda, Durgadevi Thiyagarajan, Avupati N. Syamsunderkiran, Venugopal Lalitha, Tarun K. Dutta Tags: Systemic Hypertension Source Type: research

Evaluation of the dual peroxisome proliferator–activated receptor α/γ agonist aleglitazar to reduce cardiovascular events in patients with acute coronary syndrome and type 2 diabetes mellitus: Rationale and design of the AleCardio trial
Conclusions: AleCardio will establish whether the PPAR-α/γ agonist aleglitazar improves cardiovascular outcomes in patients with diabetes and high-risk coronary disease.
Source: American Heart Journal - July 29, 2013 Category: Cardiology Authors: A. Michael Lincoff, Jean-Claude Tardif, Bruce Neal, Stephen J. Nicholls, Lars Rydén, Gregory G. Schwartz, Klas Malmberg, John B. Buse, Robert R. Henry, Hans Wedel, Arlette Weichert, Ruth Cannata, Diederick E. Grobbee Tags: Trial Design Source Type: research

Good Fat, Bad Fat The Increasingly Complex Interplay of Adipose Tissue and the Cardiovascular System ∗
Obesity is present in more than 30% of adults in the United States and is a known risk factor for a variety of cardiovascular problems, including coronary artery disease, atrial fibrillation, congestive heart failure, and stroke (1). Obesity is considered to be present when there is an excess mass of adipose tissue in the body. There is now widespread acceptance of the notion that regional fat stores might have specific local or systemic effects. The best-known example of a local fat depot with a specific effect is the case of excess fat within the abdominal cavity, which seems to contribute to insulin resistance, raised b...
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - July 1, 2013 Category: Cardiology Source Type: research

Insulin resistance negatively affects long-term outcome in non-diabetic patients with coronary artery disease after therapies to reduce atherosclerotic risk factors.
CONCLUSIONS: The presence of IR despite optimized therapies to reduce atherosclerotic risk factors represents an adverse outcome predictor in non-diabetic patients with CAD. PMID: 23810069 [PubMed - as supplied by publisher]
Source: Journal of Cardiology - June 25, 2013 Category: Cardiology Authors: Kitta Y, Nakamura T, Uematsu M, Sugamata W, Deyama J, Fujioka D, Saito Y, Kawabata K, Obata JE, Kugiyama K Tags: J Cardiol Source Type: research

Diabetes severity and the role of leisure time physical exercise on cardiovascular mortality: the Nord-Trlatin small letter o with strokendelag Health study (HUNT), Norway
Conclusions: The data suggest a more favourable effect of exercise in people with diabetes who used medication than in those who did not, suggesting that physical exercise should be encouraged as a therapeutic measure additional to medical treatment.
Source: Cardiovascular Diabetology - June 6, 2013 Category: Cardiology Authors: Børge MoeLiv Berit AugestadTom Nilsen Source Type: research

Obesity paradox in peripheral vascular disease
To prevent cardiovascular diseases, it is essential to control risk factors, among which obesity is a world-wide issue that we are currently facing . Obesity was found to be an independent cardiovascular risk factor by the Framingham Heart study, in which the participants were followed up over 26 years; a higher risk was observed in both men and women whose body weights increased after the young adult years . It has been shown that obesity, particularly visceral obesity, is closely related not only to classical cardiovascular risk factors such as dyslipidemia, diabetes, and hypertension, but also to insulin resistance, abn...
Source: Atherosclerosis - June 3, 2013 Category: Cardiology Authors: Johji Kato Tags: Invited Commentaries Source Type: research

Mediterranean diet and physical activity: An intervention study. Does olive oil exercise the body through the mind?
Several studies address how different features of unhealthy lifestyle and obesity are detrimental in cardiovascular disease . The Mediterranean diet, assumed as a paradigm of healthy nutrition, is still studied, envisaging even pharmacological effects . Other scientific contributions, without correct information, could be more negative than useful for the enhancement of healthier behavior: actually, in such studies, the successful counseling focused to secondary prevention-treatment should deserve more emphasis and dissemination. A recent investigation claims that an energy-unrestricted Mediterranean diet supplemented with...
Source: International Journal of Cardiology - May 28, 2013 Category: Cardiology Authors: Daniela Catalano, Guglielmo M. Trovato, Patrizia Pace, Giuseppe Fabio Martines, Francesca M. Trovato Tags: Letters to the Editor Source Type: research

Good Fat, Bad Fat: The Increasingly Complex Interplay of Adipose Tissue and the Cardiovascular System∗
Obesity is present in more than 30% of adults in the United States and is a known risk factor for a variety of cardiovascular problems, including coronary artery disease, atrial fibrillation, congestive heart failure, and stroke . Obesity is considered to be present when there is an excess mass of adipose tissue in the body. There is now widespread acceptance of the notion that regional fat stores might have specific local or systemic effects. The best-known example of a local fat depot with a specific effect is the case of excess fat within the abdominal cavity, which seems to contribute to insulin resistance, raised bloo...
Source: Journal of the American College of Cardiology - May 13, 2013 Category: Cardiology Authors: Sheldon E. Litwin Tags: Cardiometabolic Risk: Editorial Comment Source Type: research

Association of cardiac changes with serum adiponectin and resistin levels in obese and overweight children
Objectives: To investigate serum adiponectin and resistin levels in childhood obesity and their relationship with cardiac changes and insulin resistance. Methods: Seventy-one obese and 24 overweight children and 40 healthy children and adolescents were selected for the study. Height and weight measurements, BMI values and BMI SD score values were obtained for each individual. After blood pressure measurement, left ventricular wall thickness, left ventricular mass, stroke volume, cardiac output, systolic and diastolic functions of the left ventricle were measured using an M-mode, two dimensional color-coded echocardiography...
Source: Journal of Cardiovascular Medicine - February 19, 2013 Category: Cardiology Tags: Original articles Source Type: research

The relationship between glycaemic variability and cardiovascular complications in patients with acute myocardial infarction and type 2 diabetes: a report from the DIGAMI 2 trial
Conclusion The 1-year risk for death, reinfarction, or stroke did not relate to glycaemic variability in T2DM patients with AMI treated with insulin infusion.
Source: European Heart Journal - February 1, 2013 Category: Cardiology Authors: Mellbin, L. G., Malmberg, K., Ryden, L., Wedel, H., Vestberg, D., Lind, M. Tags: Coronary artery disease Source Type: research